Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

This is an interventional treatment trial for Pancreatic Cancer focused on measuring Patients who have confirmed cancer arising from the pancreas Read More

Inclusion Criteria:

• Is the patient 18 years of age or older.
• Does the patient have histologically or cytologically proven carcinoma of the pancreas
• Is the tumor unresectable or medically inoperable
• Does the patient have a Zubrod performance status of ≤ 2 (appendix I).
• Does the patient have an absolute neutrophil count of ≥ 1500/mm3, and platelets ≥ 100,000/mm3
• Does the patient have adequate renal function (creatinine < 2 mg/dl) and hepatic function (bilirubin < 3 mg/dl), with relief of biliary obstruction if present
• Is the patient free of significant co-morbid conditions that would preclude safe administration or completion of protocol therapy
• If the patient is of reproductive potential, has he or she agreed to use an effective method of contraception during treatment on this trial and for 6 months after treatment
• Is the patient aware of the investigational nature of the therapy such that they can provide written informed consent

Exclusion Criteria:

• Does the patient have a neuroendocrine tumor of the pancreas
• Does the patient have metastatic disease
• Does the patient have a history of abdominal radiation therapy
• Is there history of more than 1 month of therapy with single agent gemcitabine
• Has the patient used any investigational agent in the month before enrollment into the study